PL1611126T3 - Chromenonoindole - Google Patents
ChromenonoindoleInfo
- Publication number
- PL1611126T3 PL1611126T3 PL04718300T PL04718300T PL1611126T3 PL 1611126 T3 PL1611126 T3 PL 1611126T3 PL 04718300 T PL04718300 T PL 04718300T PL 04718300 T PL04718300 T PL 04718300T PL 1611126 T3 PL1611126 T3 PL 1611126T3
- Authority
- PL
- Poland
- Prior art keywords
- chromenone
- indoles
- chromenone indoles
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Reproductive Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Child & Adolescent Psychology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10315285A DE10315285A1 (de) | 2003-04-04 | 2003-04-04 | Chromenonindole |
PCT/EP2004/002351 WO2004087692A1 (de) | 2003-04-04 | 2004-03-08 | Chromenonindole |
EP04718300A EP1611126B1 (de) | 2003-04-04 | 2004-03-08 | Chromenonindole |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1611126T3 true PL1611126T3 (pl) | 2010-02-26 |
Family
ID=32981019
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL04718300T PL1611126T3 (pl) | 2003-04-04 | 2004-03-08 | Chromenonoindole |
PL377730A PL377730A1 (pl) | 2003-04-04 | 2004-03-08 | Chromenonoindole |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL377730A PL377730A1 (pl) | 2003-04-04 | 2004-03-08 | Chromenonoindole |
Country Status (18)
Country | Link |
---|---|
US (1) | US7968551B2 (pl) |
EP (1) | EP1611126B1 (pl) |
JP (1) | JP4740114B2 (pl) |
KR (1) | KR20050119673A (pl) |
CN (1) | CN1768056A (pl) |
AR (1) | AR043834A1 (pl) |
AT (1) | ATE446959T1 (pl) |
AU (1) | AU2004226279B2 (pl) |
BR (1) | BRPI0408467A (pl) |
CA (1) | CA2520892C (pl) |
DE (2) | DE10315285A1 (pl) |
DK (1) | DK1611126T3 (pl) |
ES (1) | ES2335665T3 (pl) |
MX (1) | MXPA05010483A (pl) |
PL (2) | PL1611126T3 (pl) |
PT (1) | PT1611126E (pl) |
WO (1) | WO2004087692A1 (pl) |
ZA (1) | ZA200508922B (pl) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2248524A3 (en) | 2004-08-25 | 2011-03-09 | Takeda Pharmaceutical Company Limited | Preventives/remedies for stress urinary incontinence and method of screening the same |
EP2018863B9 (en) | 2006-05-16 | 2015-02-18 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compound and use thereof |
EP2216023A4 (en) | 2007-11-15 | 2013-03-13 | Takeda Pharmaceutical | CONDENSED PYRIDINE DERIVATIVE AND USE THEREOF |
US20120253036A1 (en) | 2009-12-11 | 2012-10-04 | Yukinori Nagakura | Agent for treating fibromyalgia |
CN103304547A (zh) * | 2012-03-13 | 2013-09-18 | 中国药科大学 | 一种抗抑郁药维拉唑酮的制备方法 |
CN104045608B (zh) * | 2013-03-11 | 2016-06-01 | 天津药物研究院有限公司 | 一种取代哌嗪化合物及制备维拉佐酮中间体的方法 |
CN104059046B (zh) * | 2013-03-18 | 2017-02-08 | 江苏恩华药业股份有限公司 | 黄酮类衍生物及其应用 |
EP3027607B1 (en) | 2013-07-29 | 2020-08-26 | Sunshine Lake Pharma Co., Ltd. | Substituted heteroaryl compounds and methods of use thereof |
CN106243088B (zh) | 2015-06-03 | 2019-01-04 | 广东东阳光药业有限公司 | 取代的哌嗪化合物及其使用方法和用途 |
WO2019131902A1 (ja) | 2017-12-27 | 2019-07-04 | 武田薬品工業株式会社 | 腹圧性尿失禁および便失禁の治療薬 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4333254A1 (de) | 1993-09-30 | 1995-04-06 | Merck Patent Gmbh | Piperidine und Piperazine |
DE19730989A1 (de) * | 1997-07-18 | 1999-01-21 | Merck Patent Gmbh | Piperazin-Derivate |
-
2003
- 2003-04-04 DE DE10315285A patent/DE10315285A1/de not_active Withdrawn
-
2004
- 2004-03-08 PT PT04718300T patent/PT1611126E/pt unknown
- 2004-03-08 PL PL04718300T patent/PL1611126T3/pl unknown
- 2004-03-08 AU AU2004226279A patent/AU2004226279B2/en not_active Ceased
- 2004-03-08 MX MXPA05010483A patent/MXPA05010483A/es not_active Application Discontinuation
- 2004-03-08 DK DK04718300.9T patent/DK1611126T3/da active
- 2004-03-08 US US10/551,997 patent/US7968551B2/en not_active Expired - Fee Related
- 2004-03-08 EP EP04718300A patent/EP1611126B1/de not_active Expired - Lifetime
- 2004-03-08 KR KR1020057018642A patent/KR20050119673A/ko not_active Application Discontinuation
- 2004-03-08 WO PCT/EP2004/002351 patent/WO2004087692A1/de not_active Application Discontinuation
- 2004-03-08 ES ES04718300T patent/ES2335665T3/es not_active Expired - Lifetime
- 2004-03-08 PL PL377730A patent/PL377730A1/pl unknown
- 2004-03-08 BR BRPI0408467-5A patent/BRPI0408467A/pt not_active Application Discontinuation
- 2004-03-08 DE DE502004010296T patent/DE502004010296D1/de not_active Expired - Lifetime
- 2004-03-08 AT AT04718300T patent/ATE446959T1/de active
- 2004-03-08 JP JP2006504582A patent/JP4740114B2/ja not_active Expired - Fee Related
- 2004-03-08 CA CA2520892A patent/CA2520892C/en not_active Expired - Fee Related
- 2004-03-08 CN CNA2004800085714A patent/CN1768056A/zh active Pending
- 2004-04-02 AR ARP040101116A patent/AR043834A1/es unknown
-
2005
- 2005-11-03 ZA ZA200508922A patent/ZA200508922B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
US7968551B2 (en) | 2011-06-28 |
ES2335665T3 (es) | 2010-03-31 |
EP1611126B1 (de) | 2009-10-28 |
KR20050119673A (ko) | 2005-12-21 |
WO2004087692A1 (de) | 2004-10-14 |
CA2520892A1 (en) | 2004-10-14 |
AR043834A1 (es) | 2005-08-17 |
EP1611126A1 (de) | 2006-01-04 |
PL377730A1 (pl) | 2006-02-06 |
MXPA05010483A (es) | 2005-11-16 |
CA2520892C (en) | 2012-08-21 |
ZA200508922B (en) | 2007-02-28 |
PT1611126E (pt) | 2010-01-29 |
US20060258680A1 (en) | 2006-11-16 |
DK1611126T3 (da) | 2010-01-18 |
JP4740114B2 (ja) | 2011-08-03 |
DE10315285A1 (de) | 2004-10-14 |
CN1768056A (zh) | 2006-05-03 |
ATE446959T1 (de) | 2009-11-15 |
AU2004226279A1 (en) | 2004-10-14 |
DE502004010296D1 (de) | 2009-12-10 |
JP2006522034A (ja) | 2006-09-28 |
AU2004226279B2 (en) | 2010-10-28 |
BRPI0408467A (pt) | 2006-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI372050B (en) | (morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles | |
HK1088602A1 (en) | 2-pyridinecarboxamide derivatives | |
HK1088326A1 (en) | Piperidine-benzenesulfonamide derivatives | |
PL375111A1 (pl) | Nowe podstawione indole | |
HK1091204A1 (en) | Heteroarylcarbamoylbenzene derivative | |
ZA200603879B (en) | Substituted indazole-O-glucosides | |
HK1089443A1 (en) | Imidazol-4-yl-ethynyl-pyridine derivatives | |
IL175490A0 (en) | Substituted indazole-o-glucosides | |
ZA200603880B (en) | Substituted indole-O-glucosides | |
GB0317665D0 (en) | Qinazoline derivatives | |
EP1680131A4 (en) | SUBSTITUTED INDOLE-O-GLUCOSIDES | |
SI1682493T1 (sl) | Amidoacetonitrilni derivati | |
GB0304515D0 (en) | Standard | |
IL176562A0 (en) | Amidopyrazole derivative | |
IL175189A0 (en) | N-thiazol-2-yl-benzamide derivatives | |
ZA200508922B (en) | Chromenone indoles | |
HK1087105A1 (en) | Benzofuran derivative | |
ZA200600430B (en) | Substituted spirobenzazepines | |
IL174187A0 (en) | Carbamoyl-type benzofuran derivatives | |
PT1706373E (pt) | Derivados de amidoacetonitrilo | |
GB0319793D0 (en) | Pyridinylmorpholine derivatives | |
GB0319423D0 (en) | Lamp | |
AU2003280821A8 (en) | Beauveriolide derivative | |
TWI341309B (en) | Heteroarylcarbamoylbenzene derivatives | |
AU154939S (en) | Spotlight |